Despite new methodologies and flexible regulatory pathways, CNS biopharmaceuticals still face significant safety assessment ...

HOUSTON, TX / ACCESS Newswire / February 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments ...

Sage Therapeutics has been working in the area of steroid-derived compounds that affect CNS receptor signaling. A pivotal trial failed to show benefit, and they had several other clinical failures as ...

Researchers at University of Tsukuba have discovered that an immunosuppressive drug affects microglia, the resident immune ...

LG CNS recently signed a contract for a new drug development project led by the Ministry of Health and Welfare and began expanding its artificial intelligence transformation (AX) business in the ...